Patent Assignment
Reel/Frame 015612/0195
Document Previously Recorded at Reel 015469 Frame 0488 Contained Errors in Patent Number 5,313,177, Document Rerecorded to Correct Errors on Stated Reel.
Recorded: 2005-01-21
Received: 2005-01-21
Pages: 24
Assignor
PROCYON BIOPHARMA INC.
Executed: 2003-04-08
Assignee
INVESTISSEMENT QUEBEC
1200 ROUTE DE L'EGLISE, SUITE 500, STE-FOY, QUEBEC, CAX, G1V 5A3, CANADA
Covered Properties
(10)
PSP94 Diagnostic Reagents and Assays
Application:
10/429,668 →
Aromatic Derivatives as Hiv Aspartyl Protease Inhibitors
Application:
10/326,488 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
10/244,672 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
10/244,644 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
10/244,383 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
10/244,622 →
Pyridoxal-5-Phosphate Derivatives as Hiv Integrase Inhibitors
Application:
10/183,468 →
Urea Derivatives as Hiv Aspartyl Protease Inhibitors
Application:
10/143,095 →
Aromatic Derivatives with Hiv Integrase Inhibitory Properties
Application:
09/963,329 →
Hiv Protease Inhibitors Based on Amino Acid Derivatives
Application:
09/781,219 →